OS Therapies Inc — Form 8-K
Filed September 10, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 72/100
What the filing says
On September 10, 2026, OS Therapies filed a prospectus supplement registering 5,874,094 shares for resale by selling stockholders, comprising: 600,000 common shares, 900,000 shares from pre-funded warrant exercises, 1,500,000 shares from warrant exercises, and 2,874,094 shares from conversion of senior secured convertible notes. This represents significant dilution relative to the company's ~$49.6M market cap.
Why this rating
Heavy dilution (~12% of current market cap in potential shares) from existing security conversions; not new financing but resale registration of already-issued securities, creating near-term selling pressure risk.
Price action (we called it negative)
before filing · preread $1.81 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 10, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.